MicroRNA-455–3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer’s disease

This publication has 131 references indexed in Scilit:

• LncRNA SNHG15 Knockdown Protects Against OGD/R-Induced Neuron Injury by Downregulating TP53INP1 Expression via Binding to miR-455-3p
  Neurochemical Research, 2021
• LncRNA promoted inflammatory response in ischemic heart failure through regulation of miR-455-3p/TRAF6 axis
  Inflammation Research, 2020
• Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
  Molecular Oncology, 2018
• Up‐regulation of miR‐455‐5p by the TGF‐β–SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B
  The Journal of Pathology, 2016
• Alteration of the microRNA network during the progression of Alzheimer's disease
  EMBO Molecular Medicine, 2013
• The expression and function of microRNAs in chondrogenesis and osteoarthritis
  Arthritis & Rheumatism, 2011
• Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β
  Journal of Molecular Neuroscience, 2011
• Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway?
  Journal of Neuroscience Research, 2006
• Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
  Neurodegeneration, 1996
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
  Annals of Neurology, 1991